These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 10612798)

  • 61. NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells.
    Kawachi Y; Maruyama H; Ishitsuka Y; Fujisawa Y; Furuta J; Nakamura Y; Ichikawa E; Furumura M; Otsuka F
    Exp Dermatol; 2013 Apr; 22(4):262-5. PubMed ID: 23528211
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tissue culture studies of neurofibromatosis: effects of axolemmal fragments and cyclic adenosine 3',5'-monophosphate analogues on proliferation of Schwann-like and fibroblast-like neurofibroma cells.
    Sobue G; Sonnenfeld K; Rubenstein AE; Pleasure D
    Ann Neurol; 1985 Jul; 18(1):68-73. PubMed ID: 2994552
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.
    Muir D; Neubauer D; Lim IT; Yachnis AT; Wallace MR
    Am J Pathol; 2001 Feb; 158(2):501-13. PubMed ID: 11159187
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Delayed rectifier K currents in NF1 Schwann cells. Pharmacological block inhibits proliferation.
    Fieber LA; González DM; Wallace MR; Muir D
    Neurobiol Dis; 2003 Jul; 13(2):136-46. PubMed ID: 12828937
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brachial plexopathy due to malignant peripheral nerve sheath tumor in neurofibromatosis type 1: case report and subject review.
    Pacelli J; Whitaker CH
    Muscle Nerve; 2006 May; 33(5):697-700. PubMed ID: 16323217
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
    Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
    Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
    Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
    Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Neurofibromatosis (NF1) and neuroleprosy: immunoreaction against pathologic Schwann-cells. Physiopathogenetic observations].
    Gerosa PL; Spinelli M; Giussani G; Vai C; Fontana A; Canepari C
    Minerva Med; 2001 Apr; 92(2):89-97. PubMed ID: 11323571
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fluorescence in situ hybridization analysis of allelic losses involving the long arm of chromosome 17 in NF1-associated neurofibromas.
    De Luca A; Bernardini L; Ceccarini C; Sinibaldi L; Novelli A; Giustini S; Daniele I; Calvieri S; Mingarelli R
    Cancer Genet Cytogenet; 2004 Apr; 150(2):168-72. PubMed ID: 15066327
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas.
    Li Y; Liu J; Huang J; Wei C; Ge L; Chung M; Zhu B; Guo Z; Zheng T; Li H; Gu Y; Wang W; Li Q; Wang Z
    Cancer Lett; 2024 Sep; 599():217151. PubMed ID: 39094827
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
    Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
    Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.
    Woodruff JM
    Am J Med Genet; 1999 Mar; 89(1):23-30. PubMed ID: 10469433
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells.
    Ferrer M; Gosline SJC; Stathis M; Zhang X; Guo X; Guha R; Ryman DA; Wallace MR; Kasch-Semenza L; Hao H; Ingersoll R; Mohr D; Thomas C; Verma S; Guinney J; Blakeley JO
    Sci Data; 2018 Jun; 5():180106. PubMed ID: 29893754
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma.
    Beert E; Brems H; Renard M; Ferreiro JF; Melotte C; Thoelen R; De Wever I; Sciot R; Legius E; Debiec-Rychter M
    Genes Chromosomes Cancer; 2012 Sep; 51(9):852-7. PubMed ID: 22585738
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clonal chromosome abnormalities in a plexiform cellular schwannoma.
    Joste NE; Racz MI; Montgomery KD; Haines S; Pitcher JD
    Cancer Genet Cytogenet; 2004 Apr; 150(1):73-7. PubMed ID: 15041228
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas.
    Serra E; Rosenbaum T; Nadal M; Winner U; Ars E; Estivill X; Lázaro C
    Nat Genet; 2001 Jul; 28(3):294-6. PubMed ID: 11431704
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.
    Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L
    Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A possible paracrine hedgehog signalling pathway in neurofibromas from patients with neurofibromatosis type 1.
    Endo H; Utani A; Matsumoto F; Kuroki T; Yoshimoto S; Ichinose M; Shinkai H
    Br J Dermatol; 2003 Feb; 148(2):337-41. PubMed ID: 12588389
    [TBL] [Abstract][Full Text] [Related]  

  • 79. How does the Schwann cell lineage form tumors in NF1?
    Carroll SL; Ratner N
    Glia; 2008 Nov; 56(14):1590-1605. PubMed ID: 18803326
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
    Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
    Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.